Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
San Diego, California, Jan. 04, 2018 -- R.O.S. (Radiology Oncology Systems, Inc.) is pleased to announce the installation of the first SR Pulse 710™ 1.5T wide-bore MRI system in the United States. The FDA-approved, Swissray-manufactured system was installed at Ackerman Cancer Center in Jacksonville, Florida.
Scot Ackerman, M.D. stated “At Ackerman Cancer Center, we want to provide the most advanced and comfortable technology for our patients. The SR Pulse 710 allows us to do both – the openness of the bore reduces claustrophobia and the ability to perform DWI results in more accurate imaging so we can develop the best clinical plan to cure patients.”
The sale of the SR Pulse 710 was executed by Radiology Oncology Systems of San Diego, California, a Swissray MRI distributor. R.O.S. helps radiation oncology and diagnostic imaging facilities around the world secure quality, cost-effective equipment.
About Radiology Oncology Systems
For over 20 years, Radiology Oncology Systems has provided to radiation oncology and diagnostic imaging facilities around the world with quality, cost-effective, new and pre-owned, medical equipment. R.O.S. supplies high-quality pre-owned linear accelerators (LINACs), CT scanners, PET/CT Scanners, MRI systems, and more, to practices around the globe, ensuring that the most reliable equipment solutions reach those who need it the most. For more information, visit www.OncologySystems.com or email [email protected].
Ackerman Cancer Center
Ackerman Cancer Center is a private, physician-owned radiation oncology practice with offices in Northeast Florida. With more than 25 years of experience, the interdisciplinary team is dedicated to the highest level of care for patients and their families. The center offers advanced radiation treatment options, including Proton Therapy, on-site diagnostic services and comprehensive support services, including oncology social workers and dietitians. Learn more at www.AckermanCancerCenter.com.
About Swissray International, Inc.
For over twenty-five years, Swissray has been recognized as the industry’s pioneer in the design and manufacture of state-of-the-art Digital Radiography solutions used by radiography professionals and healthcare facilities around the globe. Swissray expanded its medical device offerings to include the Norland Bone Densitometer product line in 2013. Swissray entered the MRI market in 2016 with the SR Pulse 710. For more information, contact Cameron Cox, Vice President of Sales and Marketing, (800) 903-5543, or www.Swissray.com.
Katie Witherall VP, Operations Radiology Oncology Systems Office: (858) 454.8100 [email protected] http://OncologySystems.com
